Publicaciones en colaboración con investigadores/as de Centro de Investigación Médica Aplicada (145)

2024

  1. Biomaterials-Based Antioxidant Strategies for the Treatment of Oxidative Stress Diseases

    Biomimetics, Vol. 9, Núm. 1

2023

  1. JNK Activation in Alzheimer’s Disease Is Driven by Amyloid β and Is Associated with Tau Pathology

    ACS Chemical Neuroscience

  2. JNK3 Overexpression in the Entorhinal Cortex Impacts on the Hippocampus and Induces Cognitive Deficiencies and Tau Misfolding

    ACS Chemical Neuroscience, Vol. 14, Núm. 11, pp. 2074-2088

  3. Lipid nanoparticles for siRNA delivery in cancer treatment

    Journal of Controlled Release, Vol. 361, pp. 130-146

2022

  1. Mechanistic modelling of enzyme-restoration effects of new recombinant liver-targeted proteins in acute intermittent porphyria

    British Journal of Pharmacology, Vol. 179, Núm. 14, pp. 3815-3830

  2. Prognostic Value of Serum Paraprotein Response Kinetics in Patients With Newly Diagnosed Multiple Myeloma

    Clinical Lymphoma, Myeloma and Leukemia, Vol. 22, Núm. 9, pp. e844-e852

  3. Recombinant porphobilinogen deaminase targeted to the liver corrects enzymopenia in a mouse model of acute intermittent porphyria

    Science Translational Medicine, Vol. 14, Núm. 627

  4. The Cognitive Improvement and Alleviation of Brain Hypermetabolism Caused by FFAR3 Ablation in Tg2576 Mice Is Persistent under Diet-Induced Obesity

    International Journal of Molecular Sciences, Vol. 23, Núm. 21

  5. Trimethylamine N-oxide (TMAO) drives insulin resistance and cognitive deficiencies in a senescence accelerated mouse model

    Mechanisms of Ageing and Development, Vol. 204

  6. p27, The Cell Cycle and Alzheimer´s Disease

    International Journal of Molecular Sciences, Vol. 23, Núm. 3

2021

  1. Astrocytic GLUT1 ablation improves systemic glucose metabolism and promotes cognition

    Alzheimer's & dementia : the journal of the Alzheimer's Association, Vol. 17, pp. e058650

  2. Corticosteroid-binding-globulin (CBG)deficient mice show high pY216-GSK3β and phosphorylated-Tau levels in the hippocampus

    PLoS ONE, Vol. 16, Núm. 2 February

  3. Delivery of cardiovascular progenitors with biomimetic microcarriers reduces adverse ventricular remodeling in a rat model of chronic myocardial infarction

    Acta Biomaterialia, Vol. 126, pp. 394-407

  4. Dual activity of PD-L1 targeted Doxorubicin immunoliposomes promoted an enhanced efficacy of the antitumor immune response in melanoma murine model

    Journal of Nanobiotechnology, Vol. 19, Núm. 1

  5. Extracellular vesicle-based therapeutics for heart repair

    Nanomaterials, Vol. 11, Núm. 3, pp. 1-30

  6. Influence of culinary process on free and bound (poly)phenolic compounds and antioxidant capacity of artichokes

    International Journal of Gastronomy and Food Science, Vol. 25

  7. Modulation of intratumoural myeloid cells, the hallmark of the anti-tumour efficacy induced by a triple combination: tumour-associated peptide, TLR-3 ligand and α-PD-1

    British Journal of Cancer, Vol. 124, Núm. 7, pp. 1275-1285

  8. Optimization of a GDNF production method based on Semliki Forest virus vector

    European Journal of Pharmaceutical Sciences, Vol. 159

  9. Preclinical evaluation of the safety and immunological action of allogeneic ADSC-collagen scaffolds in the treatment of chronic ischemic cardiomyopathy

    Pharmaceutics, Vol. 13, Núm. 8

  10. Semi-mechanistic model for the antitumor response of a combination cocktail of immuno-modulators in non-inflamed (Cold) tumors

    Cancers, Vol. 13, Núm. 20